Structures by: Musina E. I.
Total: 37
[Bis(3,7-dibenzyl-1,5-di(1?-(R)-phenylethyl)-1,5-diaza-3,7-diphosphacyclooctane)- tetrafluoroboratoiron(II)] tetrafluoroborate
3(C68H68BF4FeN4P4),2(BF4),15(C3H6O),[solvent]
Molecules (Basel, Switzerland) (2020) 25, 17 3775
a=22.651(2)Å b=22.651(2)Å c=15.3431(17)Å
α=90° β=90° γ=120°
[Bis(3,7-dibenzyl-1,5-di(1-(R)-phenylethyl)-1,5-diaza-3,7-diphosphacyclooctane)- bis(acetonitrile)iron(II)] tetrafluoroborate
C72H86FeN6P4,2(BF4),2(C2H3N)
Molecules (Basel, Switzerland) (2020) 25, 17 3775
a=13.7178(14)Å b=20.452(2)Å c=27.659(3)Å
α=90° β=90° γ=90°
C27H36Cu2N3P32,2(BF41)
C27H36Cu2N3P32,2(BF41)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 34 11997-12008
a=10.1721(5)Å b=12.2241(6)Å c=14.7284(7)Å
α=90.6109(11)° β=103.3744(11)° γ=99.2242(13)°
C27H36BR0.18Cl0.82Cu2N3P31,CL1,3(H2O)
C27H36BR0.18Cl0.82Cu2N3P31,CL1,3(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 34 11997-12008
a=14.2957(2)Å b=14.2957(2)Å c=17.8833(2)Å
α=90° β=90° γ=120°
C30H42Cu2N3P32,2(BF41),CH2Cl2
C30H42Cu2N3P32,2(BF41),CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 34 11997-12008
a=14.598(2)Å b=17.269(2)Å c=31.380(4)Å
α=90° β=100.502(6)° γ=90°
C27H36BrCu2N3P31,Br1
C27H36BrCu2N3P31,Br1
Dalton transactions (Cambridge, England : 2003) (2020) 49, 34 11997-12008
a=25.0528(18)Å b=13.4498(10)Å c=18.7389(13)Å
α=90° β=94.492(3)° γ=90°
10-(m-fluorophenyl)phenoxarsine
C18H12AsFO
Dalton transactions (Cambridge, England : 2003) (2020) 49, 2 482-491
a=9.0199(14)Å b=11.945(2)Å c=13.587(2)Å
α=90° β=107.600(6)° γ=90°
Tetra-(μ^3^-iodo)-tetrakis(10-(p-fluorophenyl)phenoxarsine)copper(I)
C72H48As4Cu4F4I4O4
Dalton transactions (Cambridge, England : 2003) (2020) 49, 2 482-491
a=16.4495(7)Å b=16.4495(7)Å c=12.6800(5)Å
α=90° β=90° γ=90°
Tetra-(μ^3^-iodo)-tetrakis(10-(p-ethoxyphenyl)phenoxarsine)copper(I)
C80H68As4Cu4I4O8,C2H3N
Dalton transactions (Cambridge, England : 2003) (2020) 49, 2 482-491
a=12.4737(6)Å b=13.1687(6)Å c=25.6324(12)Å
α=77.387(2)° β=76.819(2)° γ=83.848(2)°
10-(o-methoxyphenyl)phenoxarsine
C19H15AsO2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 2 482-491
a=16.010(4)Å b=29.907(6)Å c=6.3046(13)Å
α=90° β=90° γ=90°
Tetra-(μ^3^-iodo)-tetrakis(10-(o-methoxyphenyl)phenoxarsine)copper(I)
C76H60As4Cu4I4O8
Dalton transactions (Cambridge, England : 2003) (2020) 49, 2 482-491
a=21.6406(17)Å b=21.6406(17)Å c=15.3192(15)Å
α=90° β=90° γ=90°
Dichloro(1,5-bis(p-tolyl)-3,7-bis(pyridine-2-yl)-1,5-diaza-3,7-diphosphacyclooctane)gold(I) dimethylsulfoxyde solvate
C28H30Au2Cl2N4P2,C2H6OS
New J. Chem. (2016)
a=8.9621(12)Å b=10.9006(15)Å c=17.225(2)Å
α=90.00° β=97.285(2)° γ=90.00°
Dichloro(1,5-bis(p-tolyl)-3,7-bis(pyridine-2-yl)-1,5-diaza-3,7- diphosphacyclooctane)gold(I) acetonitrile solvate
C28H30Au2Cl2N4P2,C2H3N
New J. Chem. (2016)
a=20.270(12)Å b=18.845(11)Å c=20.136(12)Å
α=90.00° β=119.588(6)° γ=90.00°
C28H30Au2Cl2N4P2,C3H6O
C28H30Au2Cl2N4P2,C3H6O
CrystEngComm (2016) 18, 39 7629
a=8.8698(2)Å b=10.6900(3)Å c=17.5273(5)Å
α=90° β=96.988(3)° γ=90°
C28H30Au2Cl2N4P2
C28H30Au2Cl2N4P2
CrystEngComm (2016) 18, 39 7629
a=15.3277(5)Å b=8.8720(2)Å c=14.8008(6)Å
α=90° β=112.309(4)° γ=90°
C28H30Au2Cl2N4P2,2(C3H6O)
C28H30Au2Cl2N4P2,2(C3H6O)
CrystEngComm (2016) 18, 39 7629
a=24.029(4)Å b=16.9105(16)Å c=12.0433(18)Å
α=90° β=124.55(2)° γ=90°
C27H36BrCu2N3P31,2(C2H6O),Br1
C27H36BrCu2N3P31,2(C2H6O),Br1
Dalton transactions (Cambridge, England : 2003) (2020) 49, 34 11997-12008
a=9.2270(5)Å b=14.0796(6)Å c=14.6601(5)Å
α=84.174(3)° β=78.867(4)° γ=76.930(4)°
C78H106Au4Cl4N14O6P4S2
C78H106Au4Cl4N14O6P4S2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 23 7715-7720
a=31.5754(6)Å b=9.8714(2)Å c=28.6481(5)Å
α=90° β=102.042(2)° γ=90°
C35.5H44.5Au2Cl2N5.5O2.5P2
C35.5H44.5Au2Cl2N5.5O2.5P2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 23 7715-7720
a=12.294(4)Å b=14.695(5)Å c=14.999(5)Å
α=90.376(4)° β=101.121(4)° γ=105.999(4)°
1,9-bis((R,S)-α-methylbenzyl)-3,7,11,15-tetramesityl-1,9-diaza-3,7,11,15-(RSSR)-tetraphosphacyclohexadecane
C62H82N2P4,4(C6H6)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 47 16977-16984
a=9.601(7)Å b=33.967(15)Å c=13.081(4)Å
α=90.00° β=109.79(4)° γ=90.00°
C69H93N3OP4
C69H93N3OP4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 47 16977-16984
a=11.6268(4)Å b=12.1381(5)Å c=13.2236(4)Å
α=88.667(3)° β=70.775(3)° γ=64.619(4)°
C78H102N2O2P4
C78H102N2O2P4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 47 16977-16984
a=11.3719(3)Å b=12.9401(5)Å c=13.1119(5)Å
α=105.891(3)° β=109.761(3)° γ=90.192(3)°
1,8-di(iso-pentyl)-3,6,10,13-tetraphenyl-1,8-diaza-3,6,10,13-tetraphosphacyclotetradecane
C42H58N2P4
Dalton Trans. (2017)
a=5.623(5)Å b=13.319(11)Å c=14.842(13)Å
α=112.941(10)° β=95.282(11)° γ=96.975(11)°
[(dicopper,diiodo(K2-P,P))(1,8-di(iso-pentyl)-3,6,10,13-tetraphenyl-1,8-diaza-3,6,10,13-tetraphosphacyclotetradecane)]
C42H58Cu2I2N2P4
Dalton Trans. (2017)
a=12.678(2)Å b=10.8332(17)Å c=17.285(3)Å
α=90° β=100.697(2)° γ=90°
[?u2(?-I)(?4-I)(?-P,N-(1-(pyridyl-2-yl)phospholane)]2
C18H24Cu4I4N2P2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 5 2250-2260
a=9.0224(8)Å b=9.4377(8)Å c=9.4869(8)Å
α=66.6150(10)° β=77.0120(10)° γ=64.3900(10)°
C20H28Cu4I4N2P2
C20H28Cu4I4N2P2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 5 2250-2260
a=9.662(5)Å b=17.858(8)Å c=9.108(5)Å
α=90° β=105.994(9)° γ=90°
?-Diiodo-?-P,N-(1-(pyridyl-2-yl)phospholane)-bis(?-P-(1-(pyridyl-2-yl)phospholane)dicopper(I)
C27H36Cu2I2N3P3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 5 2250-2260
a=11.951(4)Å b=18.183(7)Å c=15.128(5)Å
α=90.00° β=102.604(4)° γ=90.00°
C38H50N2P4
C38H50N2P4
Dalton transactions (Cambridge, England : 2003) (2015) 44, 30 13565-13572
a=21.2485(4)Å b=8.13730(10)Å c=21.7857(4)Å
α=90° β=106.726(2)° γ=90°
C68H96N4O2P4
C68H96N4O2P4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 33 12784-12789
a=32.6565(13)Å b=12.9533(4)Å c=16.2958(5)Å
α=90° β=105.974(3)° γ=90°
(RSSR)-1,11-dibenzyl-3,9,13,19-tetramesityl-1,11-diaza-3,9,13,19-tetraphosphacycloeicosane
C64H86N2P4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 33 12784-12789
a=8.978(7)Å b=11.999(9)Å c=15.378(11)Å
α=77.012(8)° β=86.156(9)° γ=70.547(8)°
1,10-Di(4?-methylbenzyl)-3,8,12,17-(RSSR)-tetra(pyridine-2?-yl)-3,8,12,17- tetraoxo-1,10-diaza?3,8,12,17?tetraphosphacyclooctadecane
C48H58N6O4P4[solvent]
The Journal of organic chemistry (2020)
a=10.11(3)Å b=11.896(16)Å c=12.699(17)Å
α=113.230(16)° β=104.32(2)° γ=98.18(2)°
C44H62N2P4
C44H62N2P4
The Journal of organic chemistry (2020)
a=11.3964(5)Å b=13.8689(7)Å c=15.4979(7)Å
α=106.832(4)° β=103.174(4)° γ=105.045(4)°
C48H66N2P4
C48H66N2P4
The Journal of organic chemistry (2020)
a=12.6527(7)Å b=13.7750(7)Å c=16.0646(5)Å
α=104.584(4)° β=98.638(3)° γ=115.784(5)°
[(1,10-Di(4?-methylbenzyl)-3,8,12,17-(RSSR)-tetra(pyridine-2?-yl)-1,10-diaza?3,8,12,17? tetraphosphacyclooctadecane)nickel(II) tetrafluoroborate
C48H58N6NiP4,2(BF4)[solvent]
The Journal of organic chemistry (2020)
a=10.9900(17)Å b=13.243(2)Å c=20.297(3)Å
α=88.718(2)° β=84.969(2)° γ=71.022(2)°
C42H58N2P4
C42H58N2P4
The Journal of organic chemistry (2020)
a=21.8967(7)Å b=8.0260(2)Å c=25.7249(11)Å
α=90° β=111.928(4)° γ=90°
[(1,10-Di((R)-(1?-phenylethyl)-3,8,12,17-(RSSR)-tetra(4-methylpyridine-2?-yl)-1,10-diaza? 3,8,12,17?tetraphosphacyclooctadecane)nickel(II) tetrafluoroborate
C52H66N6NiP4,2(BF4)
The Journal of organic chemistry (2020)
a=10.957(3)Å b=19.503(4)Å c=13.360(3)Å
α=90° β=106.509(3)° γ=90°
C42H58N2NiP42,2(BF41)
C42H58N2NiP42,2(BF41)
The Journal of organic chemistry (2020)
a=13.1558(2)Å b=21.3869(3)Å c=16.3943(3)Å
α=90° β=108.413(2)° γ=90°